Cleared Traditional

K952548 - CELSITE VENOUS SYSTEM

K952548 is an FDA 510(k) clearance for CELSITE VENOUS SYSTEM, manufactured by B.Braun Medical, Inc.. The device is a Class 2 General Hospital device with product code LJT cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K952548 · B.Braun Medical, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1995
Decision
49d
Days
Class 2
Risk

K952548 is an FDA 510(k) clearance for the CELSITE VENOUS SYSTEM. Classified as Port & Catheter, Implanted, Subcutaneous, Intravascular (product code LJT), Class II - Special Controls.

Submitted by B.Braun Medical, Inc. (Bethlehem, US). The FDA issued a Cleared decision on July 21, 1995 after a review of 49 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5965 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all B.Braun Medical, Inc. devices

FDA 510(k) Submission Details - K952548

510(k) Number K952548 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 1995
Decision Date July 21, 1995
Days to Decision 49 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
80d faster than avg
Panel avg: 129d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJT Device Classification - Class 2, Special Controls

Product Code LJT Port & Catheter, Implanted, Subcutaneous, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5965
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

All 235
Devices cleared under the same product code (LJT) and FDA review panel - the closest regulatory comparables to K952548.
TRIUMPH-1 PORT
K951814 · Horizon Medical Products, Inc. · Aug 1995
AUTO SUTURE* CHEMOSITE IMPLANTABLE DRUG DELIVERY SYSTEM**
K952748 · United States Surgical, A Division of Tyco Healthc · Aug 1995
VITAL-PORT PETIET POLYSULFONE VASCULAR ACCESS SYSTEM
K951077 · Med Institute, Inc. · Jul 1995
THEREX LOW PROFILE TITANIUM MODEL 1.0MM I.D./1.8MM O.D.
K952537 · Therex Corp. · Jul 1995
VITAL-PORT PETITE DUAL VASCULAR ACCESS SYSTEM
K951076 · Med Institute, Inc. · Jun 1995
CELSITE(TM) BRACHIAL VENOUS PORT
K945752 · B. Braun of America, Inc. · May 1995